LYMPHOMA RECEIVING CAR-T THERAPY
Clinical trials for LYMPHOMA RECEIVING CAR-T THERAPY explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA RECEIVING CAR-T THERAPY trials appear
Sign up with your email to follow new studies for LYMPHOMA RECEIVING CAR-T THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Off-the-Shelf' cancer treatment that could save time and lives
Disease control Recruiting nowThis study is testing a new type of cell therapy called Allo-QuadCAR01-T for adults with B-cell blood cancers that have come back or not responded to other treatments. Unlike current personalized cell therapies, this 'off-the-shelf' version uses donor cells that are ready immedia…
Matched conditions: LYMPHOMA RECEIVING CAR-T THERAPY
Phase: PHASE1, PHASE2 • Sponsor: AvenCell Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists track CAR-T's impact on the brain
Knowledge-focused Recruiting nowThis study aims to understand how CAR-T therapy affects thinking skills, memory, and brain structure in adults with lymphoma. Researchers will follow 120 patients receiving standard CAR-T treatment, using cognitive tests and brain scans over time. The goal is to learn about poten…
Matched conditions: LYMPHOMA RECEIVING CAR-T THERAPY
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC